<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02800226</url>
  </required_header>
  <id_info>
    <org_study_id>H13-02340</org_study_id>
    <nct_id>NCT02800226</nct_id>
  </id_info>
  <brief_title>Pilot Study Comparing 10hz vs Theta Burst Stimulation</brief_title>
  <official_title>Pilot Study Comparing 10Hz Repetitive Transcranial Magnetic Stimulation (rTMS) vs. Intermittent Theta Burst Stimulation (iTBS) for Treatment Resistant Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study aims at exploring the efficacy of iTBS compared to 10Hz protocol and explore
      potential biomarkers of treatment response
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the Hamilton Depression Rating scale 17-item (HDRS-17) score</measure>
    <time_frame>baseline, 1, 4, and 12 weeks post-treatment</time_frame>
    <description>A 50% improvement in the score is considered response to rTMS. A final score of &lt;8 is categorized as remission.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>10Hz</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High Frequency Left repetitive transcranial magnetic stimulation five days per week for 4-6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>iTBS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intermittent Theta Burst Stimulation (iTBS) five days per week for 4-6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>10Hz</intervention_name>
    <description>Magventure Cool B70 Coil with X100 Stimulator and ANT Neuronavigation System</description>
    <arm_group_label>10Hz</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iTBS</intervention_name>
    <description>Magventure Cool B70 Coil with X100 Stimulator and ANT Neuronavigation System</description>
    <arm_group_label>iTBS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  outpatients

          -  voluntary and competent to consent

          -  Mini-International Neuropsychiatric Interview (MINI) confirmed diagnosis of Major
             Depressive Disorder (MDD), single, recurrent between ages 18-65

          -  failed to achieve a clinical response to an adequate dose of an antidepressant based
             on an Antidepressant Treatment History Form (ATHF) score of ≥ 3 in the current episode
             or have been unable to tolerate at least 2 separate trials of antidepressants of
             inadequate dose and duration (ATHF 1 or 2)

          -  have a score of ≥ 18 on the Hamilton Depression Rating Score 17-item (HDRS-17)

          -  have had no increase or initiation of any psychotropic medication in the 4 weeks prior
             to screening able to adhere to the treatment schedule

          -  Pass the TMS adult safety screening (TASS) questionnaire

          -  have normal thyroid functioning based on pre-study blood work

        Exclusion Criteria:

          -  have a history of substance dependence or abuse within the last 3 months

          -  have a concomitant major unstable medical illness, cardiac pacemaker or implanted
             medication pump

          -  have active suicidal intent

          -  are pregnant

          -  have a lifetime MINI diagnosis of bipolar I or II disorder, schizophrenia,
             schizoaffective disorder, schizophreniform, delusional disorder, or current psychotic
             symptoms

          -  have a MINI diagnosis of obsessive-compulsive disorder, post-traumatic stress disorder
             (current or within the last year), anxiety disorder (generalized anxiety disorder,
             social anxiety disorder, panic disorder), or dysthymia assessed by a study
             investigator to be primary and causing greater impairment than MDD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fidel Vila-Rodriguez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Non-Invasive Neurostimulation Therapies lab, University of British Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6T2A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://NINET.CA</url>
    <description>Laboratory Website</description>
  </link>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2016</study_first_posted>
  <last_update_submitted>June 14, 2016</last_update_submitted>
  <last_update_submitted_qc>June 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

